Copyright
©The Author(s) 2017.
World J Gastroenterol. Feb 14, 2017; 23(6): 1051-1058
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Published online Feb 14, 2017. doi: 10.3748/wjg.v23.i6.1051
Table 5 Clinical outcome of all patients with esophageal squamous cell carcinoma n (%)
| Group A (n = 254) | Group B (n = 307) | P value | |
| Occurrence of advanced metachronous HNSCC | 7 (2.8) | 0 | 0.003 |
| Loss of laryngeal function | 6 (2.4) | 0 | 0.008 |
| Outcome | < 0.001 | ||
| Alive | 172 (68) | 254 (83) | |
| Dead | 82 (32) | 53 (17) | |
| ESCC | 43 (17) | 41 (13) | 0.284 |
| HNSCC | 6 (2.4) | 0 | 0.018 |
| Other cancer | 6 (2.4) | 4 (1.3) | 0.360 |
| Gastric cancer | 3 (1.2) | 0 | 0.092 |
| Lung cancer | 0 | 2 (0.7) | 0.0503 |
| Lymphoma | 1 (0.4) | 1 (0.3) | > 0.999 |
| HCC | 1 (0.4) | 1 (0.3) | > 0.999 |
| Prostate cancer | 1 (0.4) | 0 | 0.452 |
| Other/unknown | 27 (11) | 8 (2.6) | < 0.0001 |
| Radiation pneumonia | 8 (8.1) | 1 (0.3) | 0.013 |
| Heart failure | 6 (2.4) | 1 (0.3) | 0.050 |
- Citation: Morimoto H, Yano T, Yoda Y, Oono Y, Ikematsu H, Hayashi R, Ohtsu A, Kaneko K. Clinical impact of surveillance for head and neck cancer in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2017; 23(6): 1051-1058
- URL: https://www.wjgnet.com/1007-9327/full/v23/i6/1051.htm
- DOI: https://dx.doi.org/10.3748/wjg.v23.i6.1051